These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11835959)

  • 1. Limitations of a meta-analysis investigating the association between cancer and statin use.
    Iwata H; Aoyama T; Kusumi E; Hamaki T; Kami M
    Am J Med; 2002 Feb; 112(2):157-8. PubMed ID: 11835959
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins and cancer: a case of meta-uncertainty.
    Guallar E; Goodman SN
    Am J Med; 2001 Jun; 110(9):738-40. PubMed ID: 11403761
    [No Abstract]   [Full Text] [Related]  

  • 3. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T; Ishigami M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-drug interactions and statin therapy.
    Trifiro G
    South Med J; 2006 Dec; 99(12):1325-6. PubMed ID: 17233186
    [No Abstract]   [Full Text] [Related]  

  • 5. Needed: pragmatic clinical trials for statin-intolerant patients.
    Maningat P; Breslow JL
    N Engl J Med; 2011 Dec; 365(24):2250-1. PubMed ID: 22085320
    [No Abstract]   [Full Text] [Related]  

  • 6. Do statins cause cancer? A meta-analysis of large randomized clinical trials.
    Bjerre LM; LeLorier J
    Am J Med; 2001 Jun; 110(9):716-23. PubMed ID: 11403756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):219-26. PubMed ID: 23324122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin intolerance: diagnosis and remedies.
    Pirillo A; Catapano AL
    Curr Cardiol Rep; 2015 May; 17(5):27. PubMed ID: 25894795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of lipid-lowering agents (statins) during pregnancy.
    Hosokawa A; Bar-Oz B; Ito S
    Can Fam Physician; 2003 Jun; 49():747-9. PubMed ID: 12836860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering agents and risk of melanoma.
    Kirsner RS; Ramirez CC; Federman DG; Ma F
    Int J Cancer; 2005 Nov; 117(2):333; author reply 334. PubMed ID: 15900582
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ezetimibe: caution in the face of doubt].
    Araujo F; Mateo de Castro J; Encinas Barrios C
    Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins differ significantly in their anti-inflammatory activity.
    Kwatra SG
    J Am Acad Dermatol; 2011 Dec; 65(6):1229; author reply 1229-30. PubMed ID: 22082842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced myopathies].
    Ando H; Fujimura A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():390-3. PubMed ID: 18074569
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhabdomyolysis and lipid-lowering drugs.
    Tenenbaum A; Fisman EZ; Motro M
    JAMA; 2005 Mar; 293(12):1448; author reply 1448-9. PubMed ID: 15784863
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin treatment does not cause cancer.
    Steinberg D
    J Am Coll Cardiol; 2008 Sep; 52(14):1148-9. PubMed ID: 18804741
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with cerivastatin and gemfibrozil causing rhabdomyolysis: is the interaction predictable?
    Tomlinson B; Lan IW
    Am J Med; 2001 Jun; 110(8):669-70. PubMed ID: 11388340
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil.
    Alexandridis G; Pappas GA; Elisaf MS
    Am J Med; 2000 Aug; 109(3):261-2. PubMed ID: 11023440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.